ストックスクリーナーアプリを入手
25.98
8.48%
2.03
Mbx Biosciences Inc (MBX) 最新ニュース
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ - GlobeNewswire
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting - GlobeNewswire Inc.
MBX Biosciences (NYSE:MBX) Trading Down 4.1% - MarketBeat
MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - PR Newswire
HighVista Strategies LLC Lowers Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX) - Defense World
Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Lelezard
330 Shares in Monolithic Power Systems, Inc. (NASDAQ:MPWR) Bought by Brighton Jones LLC - Defense World
Westwood Holdings Group Inc. Grows Holdings in Mplx Lp (NYSE:MPLX) - Defense World
Hagens Berman Reminds MacroGenics (MGNX) Investors of the Pending Class Action Lawsuit with a Lead Plaintiff - EIN News
MGNX Deadline: MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit - Lelezard
Bridges Investment Management Inc. Invests $2.87 Million in Mplx Lp (NYSE:MPLX) - Defense World
Mplx Lp (NYSE:MPLX) Shares Acquired by Parallel Advisors LLC - Defense World
Upstream Bio goes public amid spate of IPOs - The Pharma Letter
Life Sciences X. L.P. Frazier Acquires 625,000 Shares of MBX Biosciences, Inc. (NYSE:MBX) Stock - Defense World
Edward T. Mathers Purchases 500,000 Shares of MBX Biosciences, Inc. (NYSE:MBX) Stock - Defense World
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir By Investing.com - Investing.com South Africa
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir By Investing.com - Investing.com Canada
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir By Investing.com - Investing.com Australia
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir - Investing.com India
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir - Investing.com
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir By Investing.com - Investing.com UK
Private Advisor Group LLC Has $660,000 Stock Holdings in Monolithic Power Systems, Inc. (NASDAQ:MPWR) - Defense World
Barclays Lowers Mplx (NYSE:MPLX) Price Target to $45.00 - Defense World
WINTON GROUP Ltd Makes New $633,000 Investment in Monolithic Power Systems, Inc. (NASDAQ:MPWR) - MarketBeat
MBX Biosciences director buys $10 million in IPO shares By Investing.com - Investing.com Australia
MBX Biosciences insider purchases $8 million in company stock By Investing.com - Investing.com South Africa
MBX Biosciences insider buys $8 million in company stock By Investing.com - Investing.com South Africa
MBX Biosciences insiders purchase $10 million in stock By Investing.com - Investing.com South Africa
MBX Biosciences director buys $8 million in company stock - Investing.com India
MBX Biosciences insider purchases $8 million in company stock By Investing.com - Investing.com Canada
MBX Biosciences director buys $8 million in company stock - Investing.com
MBX Biosciences insider purchases $8 million in company stock - Investing.com
MBX Biosciences director buys $8 million in company stock By Investing.com - Investing.com UK
MBX Biosciences insider purchases $8 million in company stock - Investing.com India
MBX Biosciences insider buys $8 million in company stock By Investing.com - Investing.com Canada
MBX Biosciences insider buys $8 million in company stock - Investing.com
MBX Biosciences insider buys $8 million in company stock - Investing.com India
MBX Biosciences insiders purchase $10 million in stock By Investing.com - Investing.com Canada
MBX Biosciences director buys $12m in company stock By Investing.com - Investing.com South Africa
MBX Biosciences director buys $10 million in IPO shares By Investing.com - Investing.com South Africa
NEA 17 LP buys $8 million in MBX Biosciences shares - Investing.com
MBX Biosciences insider buys $8 million in company stock By Investing.com - Investing.com UK
MBX Biosciences insiders purchase $10 million in stock By Investing.com - Investing.com Australia
OrbiMed executives purchase $12 million of MBX Biosciences stock - Investing.com India
MBX Biosciences insiders purchase $10 million in stock - Investing.com India
MBX Biosciences director buys $10 million in IPO shares - Investing.com India
OrbiMed executives purchase $12 million of MBX Biosciences stock By Investing.com - Investing.com UK
MBX Biosciences director buys $12m in company stock By Investing.com - Investing.com Canada
MBX Biosciences director buys $10 million in IPO shares - Investing.com
MBX Biosciences director buys $12m in company stock - Investing.com India
MBX Biosciences director buys $12 million in company stock - Investing.com
MBX Biosciences director buys $10 million in IPO shares By Investing.com - Investing.com UK
MBX Biosciences director buys $12m in company stock By Investing.com - Investing.com Australia
MBX Biosciences director buys $12 million in company stock By Investing.com - Investing.com UK
Bicara Leads Trio of US Biotech IPOs Raising $703 Million - MSN
Wilson Sonsini Advises MBX Biosciences on Patents Matters Related to IPO - Wilson Sonsini
MBX Biosciences director buys $10 million in IPO shares By Investing.com - Investing.com Canada
MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - ForexTV.com
MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip
MBX Biosciences Announces Closing of Upsized Initial Public - GlobeNewswire
MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - StockTitan
Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN
Bicara, MBX Bio lead gainers as biotech trio makes trading debut - MSN
MBX Biosciences raises $163.2 million in US IPO - MSN
Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News
Trio of first-day pops may bode well for biotech IPO window - BioCentury
Biotech Startups Make Pre-Election Sprint to the Public Markets - The Wall Street Journal
Carmel-based MBX Biosciences shares jump 48% in Nasdaq debut - Inside INdiana Business
Carmel-based MBX Biosciences shares jump 48% in Nasdaq debut - Indianapolis Business Journal
Biotech trio revives the IPO market - Axios
Biotech IPO Shares Climb in Trading Debuts After Deals Upsized | Stock Market News - Mint
Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha
Biotech IPO Shares Climb in Debuts After Deals Upsized - BNN Bloomberg
MBX Biosciences Opens At $23, IPO Priced At $16 By Investing.com - Investing.com Canada
0.05%
4.86%
大文字化:
|
ボリューム (24 時間):